Biesma, B <br/><br/>
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2011 
 - 1520-1527 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq637  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma, Bronchiolo-Alveolar--drug therapy<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Carcinoma, Large Cell--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Geriatric Assessment<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Paclitaxel--administration & dosage<br/>Quality of Life<br/>Survival Rate<br/>Treatment Outcome<br/>Gemcitabine